Inspira Technologies OXY B.H.N. Ltd. announced that Professor Daniel Brodie has joined company's Scientific Advisory Board. Prof. Brodie's appointment to the Scientific Advisory Board follows the appointments of Prof. Eddy Fan and Dr. Stephan Ledot. Prof. Brodie is the Section Chief for Critical Care within the Division of Pulmonary, Allergy and Critical Care Medicine, the Director of the Adult ECMO Program and the Director of the Center for Acute Respiratory Failure at the Columbia University/New York-Presbyterian Hospital.
Inspira Technologies Oxy B.H.N. Ltd.
Equities
IINN
IL0011715781
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.86 USD | -1.59% | -0.95% | +77.54% |
1st Jan change | Capi. | |
---|---|---|
+77.54% | 32.68M | |
+2.67% | 3.48B | |
-11.37% | 156M | |
-14.72% | 81.85M | |
+30.43% | 59.71M |
- Stock Market
- Equities
- IINN Stock
- News Inspira Technologies Oxy B.H.N. Ltd.
- Inspira Technologies OXY B.H.N. Ltd. Appoints Professor Daniel Brodie to the Scientific Advisory Board